CERE - Cerevel Therapeutics Inc Profit before interest, taxes and amortization
Global risks and sanctions complicate component logistics and patent protection for Cerevel Therapeutics (CERE). The baseline EBITDA level on GURU.Markets includes cash dynamics, where the metric determines the parameter status. Cerevel Therapeutics (CERE) is developing therapies for schizophrenia and Parkinson's disease with support from AbbVie, attracting elite neurobiologists through generous funding and ambitious goals.
Cerevel Therapeutics, Inc. - analytical breakdowns and key metrics (CERE)
- stock quotes and analyst forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
Debt to Equity Cerevel Therapeutics|CERE - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Cerevel Therapeutics Inc|CERE - Company Total Debt|Debt to Book Capital Cerevel Therapeutics|CERE - Company Long-Term Debts|Company Short-Term Loans and Borrowings Cerevel Therapeutics|Immediate Liquidity cerevel.com
- net income and valuation multiples indicators:
CERE - Company Net Income|Expected Net Income Cerevel Therapeutics|CERE - P/E Multiple|Forward P/E Multiple cerevel.com|CERE - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Cerevel Therapeutics|CERE - Operating profit EBITDA|Net earnings per one share for the last twelve months Cerevel Therapeutics|CERE - Net earnings per share for the last 12 months|Quarterly EPS earnings growth cerevel.com|CERE - Net earnings per share growth this year|Projected earnings per share increase next year Cerevel Therapeutics
Fundamental company valuation:Cerevel Corp CERE
Business stability for Cerevel Therapeutics (CERE) within the context of clinical trials for neurological drugs is constrained by colossal R&D expenditures, creating a pre-revenue plateau and eliminating any autonomous operating leverage. By analyzing the recorded EBITDA level, the investor assesses the real scale of pre-tax and pre-interest operating cash flow, which allows for the differentiation of the company's actual size from the risks of capital stagnation resulting from a loss of management flexibility.
Who Cerevel Therapeutics competes with
Income before deduction of interest, taxes and amortization BIIB|Neurocrine Biosciences - Operating profit EBITDA|Profit before interest, taxes and amortization regencellbioscience.com|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|ACAD (ACADIA Pharma) - Profit before payment of interest, taxes and amortization|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|Profit before payment of interest, taxes and amortization CPRX (catalystpharma.com)|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN: Operating profit before deduction of amortization|Amylyx Corp - Company profit before taxes, interest and amortization|TRVI: Operating profit EBITDA|praxismedicines.com - Income before deduction of interest, taxes and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Profit before interest, taxes and amortization CeriBell Inc CBLL|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating profit EBITDA Omeros Corp OMER|NGNE - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ACIU|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Neumora Corp (NMRA)|Operating profit before deduction of amortization SCLX|Operating profit EBITDA tevogen.com|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Company profit before taxes, interest and amortization CGTX|Operating profit EBITDA IKT (Inhibikase)|Operating income before deduction of amortization Cassava Pharma (SAVA)|Assertio Therapeutics - Operating profit EBITDA|Coya Therapeutics, Inc. (COYA) - Operating profit before deduction of amortization|vistagen.com (VTGN) - Profit before payment of interest, taxes and amortization|OVID - Operating income before deduction of amortization|ABOS (Acumen Pharma) - Operating profit EBITDA|Operating profit before deduction of amortization CervoMed Corporation (CRVO)|Operating profit EBITDA ATHE|CLNN - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization PepGen PEPG|Income before deduction of interest, taxes and amortization JUNS|Relmada - Operating profit EBITDA|Profit before interest, taxes and amortization Annovis Bio Corporation|gracetx.com (GRCE) - Profit before payment of interest, taxes and amortization|Operating profit before amortization AIFF|KLTO (ANEW Medical) - Operating profit EBITDA|Profit before interest, taxes and amortization NeuroSense Therapeutics, Ltd. NRSN|Operating profit before deduction of amortization RVPH (Reviva Pharmaceuticals Holdings)|Operating profit EBITDA metaviatx.com (MTVA)|Profit before payment of interest, taxes and amortization NeurAxis, Inc. NRXS|Income before deduction of interest, taxes and amortization HSDT|PASG - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Neuphoria Therapeutics Inc.|NERV: Operating profit EBITDA|Operating profit before deduction of amortization Athira Pharma Corp|ADXN (Addex Therapeutics) - Operating profit EBITDA|Profit before interest, taxes and amortization Alzamend ALZN|Profit before payment of interest, taxes and amortization Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Profit before interest, taxes and amortization|ATXI: Operating profit before deduction of amortization|BCLI: Profit before payment of interest, taxes and amortization|CARA: Operating profit EBITDA|Profit before interest, taxes and amortization Chromocell Therapeutics Corp (CHRO)|Profit before payment of interest, taxes and amortization Eliem Therapeutics, Inc.|Profit before payment of interest, taxes and amortization ITCI|Operating profit before deduction of amortization LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Income before deduction of interest, taxes and amortization|NKGen Biotech - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization NRBO (NeuroBo Pharmaceuticals Inc)|Sage Therapeutics, Inc - Operating profit EBITDA|Income before deduction of interest, taxes and amortization SNPX (Synaptogenix, Inc)|TRVN: Operating profit EBITDA|Profit before interest, taxes and amortization Vigil Neuroscience, Inc. (VIGL)|Profit before payment of interest, taxes and amortization Anew Medical
